Skip to main content

Key opinion leaders in precision medicine are gathering in Utrecht this Thursday to discuss partnering and business models in the Johnson & Johnson Innovation and JLABS organized event. A thought-provoking program with different speakers and sessions awaits the participants.

What? Partnering and Business Models in Precision Medicine
When? 16 November 2023, 11:00-18:00 CET
Hotel NH Utrecht
Organized by Johnson & Johnson Innovation and JLABS

GenomeScan is invited to join the patient stratification panel

Our Head of Oncology, Stefanie Klaver-Flores, will join the panel that leads the discussion on patient stratification. She will bring her perspective to the table not only in (immuno-) oncology, but also in next generation sequencing and multi-omics technologies, which play key roles in paving the way for personalized therapies.

The panel will include other key opinion leaders as below.

Patient stratification using data sets
Panel discussion

Maarten Timmers | Senior Director, Neuroscience Translational Science, Johnson & Johnson
Caroline Cake | CEO, Neu Health Digital
Audrey Coiffic | Engagement Manager, IQVIA
Stefanie Klaver Flores | Head of Oncology, GenomeScan B.V.
Bart Vannieuwenhuyse | Senior Director Health Information Sciences, Johnson & Johnson (moderator)

Why is this event important?

Bringing a precision medicine solution to patients comes with a unique set of challenges, especially for early-stage life sciences companies. In this event, representatives of Johnson & Johnson will discuss how to successfully navigate collaborations between startups, pharma companies, academic groups and government. They will also discuss the business models that support innovation. These will be followed by three panel discussions on 1) diagnostics & biomarkers, 2) patient stratification using data sets, 3) digital applications for Real-World Evidence studies, all of which will aim to dive further into specific issues such as:

  • Regulatory pathway and integration in standard-of-care
  • Governance of health-related data, infrastructure and system integration
  • Patient involvement, impartiality of data, and the protection of data privacy

Connect with Stefanie!

Our Head of Oncology, Stefanie Kalver-Flores will not only join the patient stratification panel but will also be happy to discuss other challenges and solutions in precision medicine with you. Don’t hesitate to reach out to her via

Leave a Reply